Autnami

Autnami combines Metformin Hydrochloride and Linagliptin for oral use, supporting glucose management. This dual-action medication is designed to help regulate blood sugar levels in adults with type 2 diabetes.

Autnami is primarily used to manage type 2 diabetes by improving blood sugar control. It combines two active ingredients: Metformin Hydrochloride, which helps reduce glucose production in the liver, and Linagliptin, which works to increase insulin production. This combination is often prescribed when diet and exercise alone are not sufficient to manage blood sugar levels effectively.

Common effects of Autnami may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting the medication. Some users may also experience headaches or a mild increase in cold-like symptoms. These effects are generally temporary and may subside as the body adjusts to the medication.

Autnami should be used with caution in individuals with kidney or liver problems. It is important to follow the advice of a healthcare provider regarding its use, especially if you have a history of pancreatic or heart issues. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Autnami may interact with certain medications, including those that affect kidney function or blood sugar levels. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.